Related Experiment Video
Updated: Jul 18, 2026
06:33
Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells
Published on: February 2, 2024
Stem cells with potential to generate insulin producing cells in man
1Division of Endocrinology, Diabetes and Clinical Nutrition, and Department of Research, University Hospital, Basel, Switzerland. henryk.zulewski@unibas.ch
Swiss Medical Weekly
|November 15, 2006
Summary
Generating insulin-producing cells from stem cells offers a promising alternative for type 1 diabetes treatment. Mesenchymal stem cells, particularly from the pancreas and adipose tissue, show potential for developing these crucial cells.
Area of Science:
- Stem cell biology
- Endocrinology
- Regenerative medicine
Background:
- Type 1 diabetes mellitus necessitates insulin-producing cell replacement for ideal treatment.
- Pancreatic islet transplantation is limited by donor organ scarcity.
- Stem cell-derived insulin-producing cells present a viable alternative.
Purpose of the Study:
- To review the development of insulin-producing cells from various stem cell sources.
- To highlight the potential of human mesenchymal stem cells for pancreatic endocrine cell differentiation.
- To focus on mesenchymal stem cells derived from pancreatic and adipose tissues.
Main Methods:
- Review of current scientific literature on stem cell differentiation into insulin-producing cells.
- Analysis of studies investigating embryonic stem cells (ESC) and adult stem cells.
- Specific examination of mesenchymal stem cells' plasticity and differentiation capacity.
Main Results:
- Embryonic stem cells (ESC) face ethical concerns and limitations in patient-specific generation.
- Adult stem cells from diverse tissues can differentiate into insulin-producing cells.
- Mesenchymal stem cells exhibit significant ex vivo plasticity, including pancreatic endocrine phenotype adoption.
Conclusions:
- Stem cell-based generation of insulin-producing cells is a promising therapeutic avenue for type 1 diabetes.
- Human mesenchymal stem cells, particularly those from pancreatic and adipose tissue, are strong candidates for this approach.
- Further research into mesenchymal stem cell differentiation holds potential for overcoming donor limitations.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...